Adicet Bio Inc (ACET) Stock Forecast & Price Target
Adicet Bio Inc · NASDAQ
$9.76+0.17 (+1.77%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Adicet Bio Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. The target range is very wide, $18.00 to $90.00 (about 5.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $38.50 sits 294% above the current $9.76. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 0% this year and 0% next, consensus EPS building from about $-1.53 next quarter toward $-4.04 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Strong Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Adicet Bio Inc.
As of Sep, 4 of 4 firms rate ACET a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ACET EPS & revenue forecast
EPS · NEXT QUARTER
$-1.53
Range $-2.12 – $-0.99 · 6 analysts · -48% YoY
Next period, 6 analysts expect Adicet Bio Inc to earn $-1.53 a share (range $-2.12 – $-0.99), versus $-2.94 a year earlier. Full-year consensus is $-6.36, growing to $-4.04 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 6 analysts · +0% YoY
Revenue is expected to reach $0 (range $0 – $0), +0.0% year-over-year. Full-year consensus is $0, rising to $28.5M next year.
Top analysts covering Adicet Bio Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ACET.
#1
Yatin Suneja
Guggenheim · Rank #21
Buy
$90.00+822.1% to target
Overall win rate
53%
+ Follow
#2
RB
Robert Burns
HC Wainwright & Co. · Rank #199
Buy
$27.00+176.6% to target
Overall win rate
41%
+ Follow
#3
EW
Edward White
HC Wainwright & Co. · Rank #290
Hold
No targeton ACET
Overall win rate
31%
+ Follow
#4
Reni J. Benjamin
JMP Securities · Rank #366
Hold
No targeton ACET
Overall win rate
32%
+ Follow
#5
Robert Driscoll
Wedbush · Rank #375
Buy
$5.00-48.8% to target
Overall win rate
30%
+ Follow
ACET stock forecast FAQ
What is ACET's average 12-month price target?+
The 4 analysts with a live target average $38.50 for Adicet Bio Inc over the next 12 months, ranging from a $90.00 high to a $18.00 low.
Is ACET stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ACET?+
The Street-high target is $90.00 (Guggenheim), and the Street-low is $18.00 (Canaccord Genuity). The average of all 4 active targets is $38.50.
How many Wall Street analysts cover ACET?+
4 analysts have an active rating on Adicet Bio Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering ACET?+
Among analysts who currently cover ACET, Yatin Suneja of Guggenheim has the strongest overall Quantellect track record (Rank #21). Their current call is Buy with a $90.00 target.
What is Adicet Bio Inc's projected EPS for next quarter?+
The consensus estimate is $-1.53 per share (range $-2.12 – $-0.99) across 6 analysts. Full-year EPS is projected at $-6.36, rising to $-4.04 the following year.
How much revenue is Adicet Bio Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $28.5M next year.
Have analysts been upgrading or downgrading ACET lately?+
As of Sep, 4 of 4 firms rate ACET a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ACET calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
